EIGRQ
Price:
$8.5
Market Cap:
$12.59M
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development of therapies for hepatitis delta virus (HDV) and other serious diseases. The company offers Zokinvy for the treatment of Hutchinson-Gilford progeria syndrome and Processing-Deficient Progeroid Laminopathies. Its product candidates include Lonafarnib, an orally available, farnesylation inhibitor, which has completed Phase 3 clinical trials for HDV infection; Peginterferon Lambda (lambda), which is in clinical development for HDV; lambda, that is in phase II and III investigator studies of mild and moderate COVID-19; and Avexitide, which is in Phase II for the treatment of congenital hyperi...[Read more]
Industry
Biotechnology
IPO Date
2014-01-30
Stock Exchange
OTC
Ticker
EIGRQ
According to Eiger BioPharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.72. This represents a change of 142.86% compared to the average of -0.30 of the last 4 quarters.
The mean historical PE Ratio of Eiger BioPharmaceuticals, Inc. over the last ten years is -2.88. The current -0.72 PE Ratio has changed 2.42% with respect to the historical average. Over the past ten years (40 quarters), EIGRQ's PE Ratio was at its highest in in the September 2023 quarter at -0.19. The PE Ratio was at its lowest in in the June 2021 quarter at -3.77.
Average
-2.88
Median
-2.76
Minimum
-5.32
Maximum
-0.14
Discovering the peaks and valleys of Eiger BioPharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 92.99%
Maximum Annual PE Ratio = -0.14
Minimum Annual Increase = -90.23%
Minimum Annual PE Ratio = -5.32
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.14 | -72.65% |
| 2022 | -0.51 | -90.23% |
| 2021 | -5.19 | -2.31% |
| 2020 | -5.32 | 10.02% |
| 2019 | -4.83 | 81.75% |
| 2018 | -2.66 | -7.30% |
| 2017 | -2.87 | 92.99% |
The current PE Ratio of Eiger BioPharmaceuticals, Inc. (EIGRQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.95
5-year avg
-3.20
10-year avg
-2.88
Eiger BioPharmaceuticals, Inc.’s PE Ratio is less than Poxel S.A. (-0.25), greater than Ceapro Inc. (-3.74), greater than Living Cell Technologies Limited (-11.55), greater than Noxopharm Limited (-5.56), greater than Progressive Care, Inc. (-0.89), less than Bionomics Limited (-0.03), greater than Rapid Dose Therapeutics Corp. (-4.32), greater than Avecho Biotechnology Limited (-11.13), less than MGC Pharmaceuticals Limited (-0.06), less than Titan Medical Inc. (13.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.25 | $13.42M | |
| -3.74 | $13.31M | |
| -11.55 | $11.39M | |
| -5.56 | $14.78M | |
| -0.89 | $13.49M | |
| -0.03 | $8.81M | |
| -4.32 | $19.93M | |
| -11.13 | $13.35M | |
| -0.06 | $12.11M | |
| 13.14 | $13.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eiger BioPharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eiger BioPharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eiger BioPharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Eiger BioPharmaceuticals, Inc. (EIGRQ)?
What is the highest PE Ratio for Eiger BioPharmaceuticals, Inc. (EIGRQ)?
What is the 3-year average PE Ratio for Eiger BioPharmaceuticals, Inc. (EIGRQ)?
What is the 5-year average PE Ratio for Eiger BioPharmaceuticals, Inc. (EIGRQ)?
How does the current PE Ratio for Eiger BioPharmaceuticals, Inc. (EIGRQ) compare to its historical average?